Filed before 2025Filed 21 November 2018
Inozyme Pharma, Inc. has sold $48.9M so far
Inozyme Pharma, Inc., a pharmaceuticals company based in Boston, MA, has sold $48.9M so far in its equity round, according to a filing dated 21 November 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 21 November 2018
- Round
- Equity round (amended filing)
- Amount sold
- $48.9M
- Offering size
- $48.9M
- Investors so far
- 14
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 1,729 tracked raises with an amount filed in 2018, and than 81% of the 42 in pharmaceuticals.
Inozyme Pharma, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 8 Jun 2020 | Amended filing | $67.4M | Another raise |
| 27 Mar 2020 | Amended filing | $33.7M | Another raise |
| 29 Mar 2019 | Amended filing | $33.7M | Another raise |
| 21 Nov 2018 | New filing | $10.7M | Another raise |
| 21 Nov 2018 | Amended filing | $48.9M | This raise |
More with NEA on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.